Journal Of Oncology

Journal Of Oncology

肿瘤学杂志

  • 3区 中科院分区

期刊简介

《Journal Of Oncology》是由Hindawi Publishing Corporation出版社于2008年创办的英文国际期刊(ISSN: 1687-8450,E-ISSN: 1687-8469),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为Medicine-Oncology。作为SCIE收录期刊(中科院 3区),本刊采用OA开放获取模式(OA占比1%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比90.70%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在0篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Oncology审稿周期约为 26 Weeks 。该刊近年被列入国际预警名单,年发文量约0篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 0 发文量

中科院分区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学
4区

中科院 SCI 期刊分区 2021年12月旧的升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
ONCOLOGY 肿瘤学
4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.9 SJR:0.805 SNIP:0.806
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q3 204 / 366

44%

期刊发文

  • Prognostic Value of a CT Radiomics-Based Nomogram for the Overall Survival of Patients with Nonmetastatic BCLC Stage C Hepatocellular Carcinoma after Stereotactic Body Radiotherapy

    Author: Wang, Lihong; Yan, Danfang; Shen, Liang; Xie, Yalin; Yan, Senxiang

    Journal: JOURNAL OF ONCOLOGY. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/1554599

  • Histone Deacetylase 1 Expression and Regulatory Network in Lung Adenocarcinoma Based on Data Mining and Implications for Targeted Treatment

    Author: Zhong, Yueyuan; Li, Mingdong; Guo, Shihui; Li, Minhua; Cao, Zitong; Luo, Xueyao; Liu, Jianhong; Liang, Runzhang; Shao, Yingqi; Yang, Yue; Chen, Xinqia; Wei, Chuzhong; Ling, Weijun; Zhu, Xiao; Huang, Yongmei

    Journal: JOURNAL OF ONCOLOGY. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/2745074

  • Cell-Free DNA in Cerebrospinal Fluid Complements the Monitoring Value of Interleukin-10 in Newly Diagnosed Primary Central Nervous System Lymphoma

    Author: Wang, Wei; Zou, DongMei; Zhuang, Zhe; Zhang, Xiao; Zhang, Li; Yin, JingJing; Jia, CongWei; Yuan, Li; Cai, Hao; Zhang, Yan; Wang, Xuan; Zhang, MeiFen; Zhou, DaoBin; Zhang, Wei

    Journal: JOURNAL OF ONCOLOGY. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/5808731

  • Activated Mast Cells Combined with NRF2 Predict Prognosis for Esophageal Cancer

    Author: Guo, Xinxin; Shen, Weitao; Sun, Mingjun; Lv, Junjie; Liu, Ran

    Journal: JOURNAL OF ONCOLOGY. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/4211885

  • Silencing UBQLN2 Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma (ESCC) via Activating p38 MAPK

    Author: Wang, Jia-Lin; Mu, Xiao-Ying; Ma, Rong; Bai, Xue-Hong; Zhao, Zhi-Jun; Wang, Yan-Yang

    Journal: JOURNAL OF ONCOLOGY. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/2339732

  • Ubiquitin-Specific Peptidase 8 Modulates Cell Proliferation and Induces Cell Cycle Arrest and Apoptosis in Breast Cancer by Stabilizing Estrogen Receptor Alpha

    Author: Zheng, Lewei; Yang, Qian; Li, Chengxin; Xu, Gaoran; Yuan, Qianqian; Hou, Jinxuan; Wu, Gaosong

    Journal: JOURNAL OF ONCOLOGY. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/8483325

  • Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis B or C: A Systematic Review and Meta-Analysis

    Author: Dong, Huijing; Xue, Chongxiang; Zheng, Yumin; Zhang, Xu; Hu, Zixin; Lu, Xingyu; Yu, Yixuan; Li, Jia; Tan, Kexin; Cui, Huijuan

    Journal: JOURNAL OF ONCOLOGY. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/2525903

  • The Interplay between RNA Editing Regulator ADAR1 and Immune Environment in Colorectal Cancer

    Author: Zheng, Guo-Liang; Zhang, Guo-Jun; Zhao, Yan; Zheng, Zhi-Chao

    Journal: JOURNAL OF ONCOLOGY. 2023; Vol. 2023, Issue , pp. -. DOI: 10.1155/2023/9315027